Posted 10 March 2016 By Zachary Brennan
Teva Pharmaceuticals will take a bite out of Pfizer's blockbuster Viagra (sildenafil citrate) sales as the US Food and Drug Administration approved a generic version of the erectile dysfunction drug on Wednesday.
But the generic savings will not come...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.